A t (9;11) translocation in childhood acute mixed leukemia
Keywords:
Leukemia, karyotipe, Epipodophillotoxin derivativeAbstract
We present the case of a child with acute lymphoid leukemia (ALL) who was morphologically classified as FAB L1 (PAS and peroxidase were negative). Remission was achieved with an ALL-type protocol (GBTLI). Five months after the discontinuation of therapy, the patient presented mixed leukemia (CD10, CD19, CD13 and CD33 were positive) with t (9;11) (p21;q23) translocation. Unfortunately, as cytogenetic and immunophenotype studies were not performed at diagnosis, two possibilities could be considered for the relapse; secondary mixed leukemia with clonal chromosome changes, or mixed leukemia from the beginning.
Downloads
References
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Proposals for the classification of the acute leukemia. Br J Hematol 1976;33:451-8.
Brandalise S, Odone V, Pereira W, Andrea M, Zanicheli M, Aranega V. Treatment results of the comparative Brazilian Cooperative Childhood ALL protocols; GBTLI 80, GBTLI 82 and GBTLI-85. Leukemia 1993; Suppl 2:5142-5.
Chen SJ, Chen Z, Derrej, Coniat M, Nvalensi F, Sigaux F, Berger R. Are most secondary lymphoblastic leukemias mixed acute leukemia? Nouv Rev Fr Hematol 1989;31:17-22.
Foo Ka, Todd RF III. Immunologic classification of leukemia and lymphoma. Blood 1986;68:1-31.
ISCN; An international system for human cytogenetic nomenclature. In: Harnden DG, KlingerHP, eds, published in collaboration with Cytogenet Cell Genet. New York: Karger, Basel, 1985.
Janossy G, Amlot P. APAAP in Immunofluorescence and immunohistochemistry. In: Klaus GGB, ed. Lymphocytes; a Practical Approach. IRL Press Oxford Press 1987: 67-108.
Kalwinsky D K, Raimondi Sc, Schell J, Mirro Jr, J, Santana Vm, Behm F, Dah Gv, Williams D. Prognostic importance of cytogenetics subgroups in de novo pediatric acute nonlymphocytic leukemia. Journ Clin Oncol 8(1):75-83.
Kaneko Y, Maseki N, Takasaki N, Sakurai M, Takeda T, Shikano, T, Hyoshi Y. Clinical and hematological characteristics in acute leukemia with 11q23 translocations. Blood 1986;67:484-91.
Murphy S. Secondary acute myeloid leukemia following treatment with epipodophyllotoxins. Journ Clin Oncol 1993;11(2):199-201.
Pedersen-Bjergaard J, Philip P, Larsen So, Jensen G, Byrsting K. Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute non lymphocytic leukemia. Blood 1990;76(6):1083-91.
Pui Ch, Behm FG, Raimondi SC, et al. Secondary acute myeloid leukemia in children treated for ALL. N Engl J Med 1989;321:136-42.
Pui Ch, Raimondi SC, Behm FG, et al. Shifts in blast cell phenotype and karyotype at relapse of childhood lymphoblastic lekemia. Blood 1986;68:1306-10.
Raimondi SC, Kalwinsky DK, Hayashi Y, Behm G, Mirro J Jr, Williams DL. Cytogenetics of childhood acute nonlymphocytic leukemia. Cancer Genet Cytogen 1989;40:13-27.
Ratain MJ, Rowley JD. Therapy-related acute myeloid leukemia secondary to inhibitors of topoisomerase II; from the bedside to target genes. Ann Oncol 1992;3 (2):107-11.
Sandberg AA. Chromosome changes and their significance in ANLL. In: The Chromosomes in Human Cancer and Leukemia, 2nd Ed. New York:Elsevier, 1990:223-312.
Sandberg AA. Cytogenetics features of special hematologic disorders, including some aspects of acute leukemia. In: The Chromosomes in Human Cancer and Leukemia, 2nd ed. New York:Elsevier, 1990:374-426
Sandoval C, Head DR, Mirro J JR, Behm FG, Ayers GB, Raimondi SC. Translocation t (9;11) (p21;q23) in pediatric de novo and secondary acute myeloblastic leukemia. Leukemia 1992;6(6):513-9.
Seabright MA. A rapid banding technique for human chromosomes. Lancet 1971;2:971.
Whtilock JA, Greer JP, Lukens JN. Epipodophyllotoxin-related leukemia: Identification of a new subset of secondary leukemia. Cancer 1990;68:600-4.
Winick NJ, Mckenna RW, Shuster JJ, et al. Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide. Journ Clin Oncol 1993;11(2):209-17.
